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ABSTRACT
Objectives Prespecified progression criteria can inform 
the decision to progress from an external randomised 
pilot trial to a definitive randomised controlled trial. 
We assessed the characteristics of progression criteria 
reported in external randomised pilot trial protocols and 
results publications, including whether progression criteria 
were specified a priori and mentioned in prepublication 
peer reviewer reports.
Study design Methodological review.
Methods We searched four journals through PubMed: 
British Medical Journal Open, Pilot and Feasibility 
Studies, Trials and Public Library of Science One. Eligible 
publications reported external randomised pilot trial 
protocols or results, were published between January 
2018 and December 2019 and reported progression 
criteria. We double data extracted 25% of the included 
publications. Here we report the progression criteria 
characteristics.
Results We included 160 publications (123 protocols 
and 37 completed trials). Recruitment and retention were 
the most frequent indicators contributing to progression 
criteria. Progression criteria were mostly reported as 
distinct thresholds (eg, achieving a specific target; 
133/160, 83%). Less than a third of the planned and 
completed pilot trials that included qualitative research 
reported how these findings would contribute towards 
progression criteria (34/108, 31%). The publications 
seldom stated who established the progression criteria 
(12/160, 7.5%) or provided rationale or justification for 
progression criteria (44/160, 28%). Most completed pilot 
trials reported the intention to proceed to a definitive trial 
(30/37, 81%), but less than half strictly met all of their 
progression criteria (17/37, 46%). Prepublication peer 
reviewer reports were available for 153/160 publications 
(96%). Peer reviewer reports for 86/153 (56%) publications 
mentioned progression criteria, with peer reviewers of 
35 publications commenting that progression criteria 
appeared not to be specified.
Conclusions Many external randomised pilot trial 
publications did not adequately report or propose 
prespecified progression criteria to inform whether to 
proceed to a future definitive randomised controlled trial.
INTRODUCTION
Pilot trials aim to determine whether a future 
definitive randomised controlled trial (RCT) 
is feasible.1 Internal pilot trials are embedded 
in the RCT design forming its first phase.2 In 
contrast, external pilot trials are small stand- 
alone studies conducted before a definitive 
RCT. Prespecified progression criteria can 
help researchers interpret the findings of an 
external randomised pilot to decide whether 
the future definitive RCT is or is not feasible, 
and whether changes should be made to 
the trial design. Progression criteria should 
be specified before the pilot trial begins (a 
priori) to avoid introducing bias associated 
with establishing progression criteria once 
external pilot trial findings are known.
A 2019 review found that less than 20% of 
randomised pilot trial protocols published 
between 2013 and 2017 reported clear 
progression criteria. Trial features, such as 
a more recent publication year and certain 
countries of origin, were associated with 
reporting progression criteria.3 The 2016 
Strengths and limitations of this study
 ► We conducted a large recent assessment of the use 
and reporting of progression criteria in publications 
reporting external randomised pilot trial protocols 
and results.
 ► As this study only investigated external randomised 
pilot trial publications, it is unclear whether the find-
ings can be generalised to other external feasibility 
study designs such as non- randomised pilot trials 
and non- pilot feasibility studies.
 ► One researcher independently screened all publica-
tions, assessed eligibility and extracted data from all 
included publications, while other members of the 
research team provided a second data extraction for 
25% of the included publications.
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Consolidated Standards of Reporting Trials (CONSORT) 
extension for reporting randomised pilot and feasibility 
trials advises that ‘at a minimum there should be some-
thing reported to suggest how the decision to progress to 
the definitive study will be made’.4 The extent to which this 
guidance has improved progression criteria reporting in 
more recently published pilot trials is unclear. Although 
previous research has investigated whether progression 
criteria are reported, the quality of progression criteria 
reporting—including how the criteria are established 
during pilot trial design and assessed on pilot trial 
completion—has not yet been investigated.
We conducted a methodological review to investigate 
the application and reporting of progression criteria in a 
recent sample of external randomised pilot trial protocol 
and results publications. The primary objective was to 
describe the reporting of progression criteria, including 
the areas of feasibility that progression criteria were based 
on as described in a published framework of reasons for 
conducting pilot trials,5 their rationale or justification 
and who established and assessed the progression criteria. 
One set of secondary objectives were to assess whether the 
progression criteria reported in pilot trial results publi-
cations were specified a priori in a published protocol 
or trial registration and whether the results publication 
reported the intention to progress to a definitive RCT. We 
also assessed the extent and context in which progression 
criteria were discussed in prepublication peer reviewer 




A protocol for this research is registered on the Open 
Science Framework:  osf. io/ bn35k.6 A summary of the 
methods used is detailed below. This review is reported 
following the Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses (PRISMA) statement.7
Eligibility criteria
We included all protocol and results publications for 
external randomised pilot trials that reported progres-
sion criteria and were published between January 2018 
and December 2019 inclusive. Progression criteria were 
defined as criteria to inform the decision to progress to a 
definitive RCT. Included publications were published in 
the English language and were not restricted by interven-
tion, health- related context or setting.
Information sources
Four journals were searched through PubMed: British 
Medical Journal (BMJ) Open, Pilot and Feasibility Studies 
(PAFS), Trials and Public Library of Science (PLoS) One. 
These journals were chosen because they are known to 
publish pilot trial protocol and results publications and 
had published the most PubMed indexed publications 
that included the terms ‘pilot’ or ‘feasibility and ‘trial’ or 
‘protocol’ in their title within 2018 and 2019. All included 
journals direct authors to the CONSORT statement8 
reporting guideline: BMJ Open and Trials advise authors 
to use the most appropriate statement extension, and the 
PAFS journal directs authors to the CONSORT Extension 
to Pilot and Feasibility Trials.4
Search terms included ‘pilot’ or ‘feasibility’ in the title, 
and ‘trial’, ‘study’ or ‘protocol’ in the title or abstract. 
See online supplemental file 1 for the full search strategy 
which was last used on 6 January 2020.
Study selection
Titles and abstracts of identified publications were 
screened against inclusion criteria. Full texts were 
retrieved for those that appeared relevant and screened 
against a predefined eligibility checklist by KM. All 
included publications were saved in EndNote V.X9 for 
Windows. Where both the protocol and corresponding 
pilot trial result publication were identified, both were 
included.
Data collection
Data extraction forms produced in Microsoft Excel 
(Office 16) were prepiloted on the first 10 trials ordered 
alphabetically to ensure usability and completeness (the 
data extraction form used can be obtained from  osf. io/ 
fxv4n). One researcher (KM) extracted the data for all 
included publications. Other team members (SEd and 
NP) conducted a second data extraction for a randomly 
selected 25% sample. As we found minimal differences 
between the two data extractions, we decided not to 
conduct double data extraction for all of the included 
publications.
From trial protocol and results publications, we 
extracted: trial characteristics (including author, year, 
journal, country, randomisation design, therapeutic area, 
intervention type, sample size target, number of arms and 
single or multicentre); feasibility objectives, outcomes 
and instances of hypothesis testing; progression criteria 
details (wording, rationale or justification, format, 
process for establishing and process for assessing); and 
references to progression criteria in prepublication peer 
reviewer reports, where these were published online and 
linked to the publication.
For completed pilot trial results publications, we also 
extracted: whether progression criteria were met; any 
reported intention to progress to a definitive RCT; any 
proposed changes to the definitive RCT design; any 
refinement of hypotheses; any comment on data quality; 
and whether progression criteria had changed from the 
corresponding protocol or trial registration publication, 
if a published protocol was not available.
Synthesis of results
Descriptive statistics (frequencies and the mean, 
median and IQR for trial sample sizes) were produced 
to describe trial characteristics and address our primary 
and secondary objectives. Data were analysed using Stata 
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V.15.0 (StataCorp).9 We report the frequency with which 
different feasibility uncertainties contributed to progres-
sion criteria using prespecified domains of reasons for 
conducting pilot trials: process, resource, management 
and scientific.5 The mean number of progression criteria 
specified per trial was also calculated.
We used narrative synthesis to describe the context in 
which progression criteria were mentioned in publicly 
available prepublication peer reviewer reports (synthe-
sised by KM). We did not use a predefined checklist 
to formally assess peer reviewer reports and we do not 
comment on the quality of peer review. Instead, we simply 
looked for any mention that progression criteria were 
not present in the prepublication manuscript, and any 
queries about rationale for progression criteria used.
We did not aim to comment on the quality of the 
evidence from the studied randomised pilot trials. We 
aimed to comment only on the quality of reporting of 
progression criteria in this sample of external randomised 
pilot trial protocol and results publications.
Patient and public involvement
Patients or the public were not involved in the design, 
conduct, reporting or dissemination plans of this research.
RESULTS
Study selection
Our search strategy identified 1030 publications. We 
screened their titles and abstracts, then assessed the full 
texts of 679 publications for eligibility. One hundred and 
sixty publications were eligible for our study. Figure 1 
shows the full PRISMA flow chart of publications included 
and excluded at each stage. We excluded many publi-
cations during full text screening as we were unable to 
identify explicit progression criteria (n=251), or where 
publications only reported a recruitment or sample 
size target (n=118). Online supplemental file 2 lists the 
included publications describing external pilot trial 
protocols and results. We found two instances where both 
the completed trial publication and protocol were identi-
fied. In these instances, both were included.
Study characteristics
Table 1 summarises the characteristics of the included 
publications. Most of the publications were pilot trial 
protocols (123/160, 77%) rather than completed pilot 
trial results (37/160, 23%). The journal with the most 
eligible publications was PAFS (77/160, 48%). Most 
publications described external pilot trials that were 
two- arm (143/160, 89%), multicentre (102/160, 64%), 
non- industry- funded (147/160, 92%) trials of counsel-
ling, lifestyle or physiotherapy interventions (94/160, 
59%). The reported trials covered 27 therapeutic areas 
and trials were from 18 countries, mostly from the UK 
(87/160, 54%).
Primary feasibility objectives were explicitly stated 
in 71/160 (44%) publications, and most publications 
reported feasibility outcomes in the methods that 
addressed all of the stated feasibility objectives (109/160, 
68%). In 50/160 (31%) of the publications, the stated 
feasibility outcomes only somewhat addressed trial objec-
tives, often because the objective stated was broad (eg, ‘to 
determine whether a future trial is feasible’) and did not 
define specific aspects of feasibility being assessed. With 
respect to data collection and assessment of feasibility 
outcomes, completely defined prespecified assessments 
or measurements were often stated (140/160, 88%). Most 
of the pilot trial publications that reported the intention 
to conduct hypothesis testing stated that this was explor-
atory or advised caution in interpretation. All but one 
publication reported multiple feasibility outcomes. The 
place in the publication where the specific uncertainties 
related to trial feasibility were first reported varied, but 
most often this was within the pilot trial feasibility objec-
tives (72/160, 45%), or within the data collection section 
describing the feasibility outcomes (26/160, 16%) or 
pilot trial assessments or measurements (23/160, 14%).
Characteristics of progression criteria
Characteristics of progression criteria are presented 
in table 2. The reported progression criteria generally 
addressed some (99/160, 62%) or all (53/160, 33%) of 
the pilot trial’s feasibility outcomes. The pilot trial publi-
cations reported a mean of 4 (mean 4.05) progression 
criteria targets per pilot trial. Recruitment (113/160, 
71%) and retention (106/160, 66%) were the most 
commonly reported indicators of feasibility to inform 
progression. In total, we identified 58 distinct areas of 
trial feasibility that contributed to progression criteria, 
which we grouped into four domains: process, resource, 
Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses (PRISMA) flow chart.
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  British Medical Journal (BMJ) Open 11 (30) 34 (28) 45 (28)
  Pilot and Feasibility Studies (PAFS) 21 (57) 56 (46) 77 (48)
  Trials 2 (5) 33 (27) 35 (22)
  Public Library of Science (PLoS) One 3 (8) 0 (0) 3 (2)
Country
  Australia 6 (16) 4 (3) 10 (6)
  Brazil 0 (0) 1 (1) 1 (1)
  Canada 4 (11) 15 (12) 19 (12)
  China 0 (0) 4 (3) 4 (3)
  Denmark 0 (0) 1 (1) 1 (1)
  Germany 1 (3) 1 (1) 2 (1)
  Korea 0 (0) 1 (1) 1 (1)
  Nepal 1 (3) 2 (2) 3 (2)
  New Zealand 2 (5) 1 (1) 3 (2)
  Norway 1 (3) 0 (0) 1 (1)
  Ireland 0 (0) 5 (4) 5 (3)
  Sweden 1 (3) 1 (1) 2 (1)
  Tanzania 0 (0) 1 (1) 1 (1)
  Thailand 0 (0) 1 (1) 1 (1)
  The Netherlands 0 (0) 2 (2) 2 (1)
  UK 19 (51) 68 (55) 87 (54)
  USA 2 (5) 14 (11) 16 (10)
  Zimbabwe 0 (0) 1 (1) 1 (1)
Funder
  Industry 2 (5) 2 (2) 4 (3)
  Non- industry 32 (86) 115 (94) 147 (92)
  A combination 1 (3) 4 (3) 5 (3)
  Unknown 2 (5) 1 (1) 3 (2)
  Trial did not receive funding 0 (0) 1 (1) 1 (1)
Therapeutic areas
  Complementary medicine 0 (0) 1 (1) 1 (1)
  Anaesthesia 1 (3) 1 (1) 2 (1)
  Cardiology 0 (0) 3 (2) 3 (2)
  Critical care 1 (3) 7 (6) 8 (5)
  Endocrinology 0 (0) 6 (5) 6 (4)
  Gastroenterology 1 (3) 3 (2) 4 (3)
  Geriatrics 1 (3) 4 (3) 5 (3)
  Hepatology 0 (0) 1 (1) 1 (1)
  Infectious diseases 0 (0) 3 (2) 3 (2)
  Musculoskeletal 6 (16) 4 (3) 10 (6)
  Nephrology 0 (0) 1 (1) 1 (1)
  Neurology 3 (8) 12 (10) 15 (9)
  Obstetrics/gynaecology 2 (5) 6 (5) 8 (5)
Continued
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  Oncology 4 (11) 7 (6) 11 (7)
  Ophthalmology 0 (0) 1 (1) 1 (1)
  Orthopaedics 2 (5) 1 (1) 3 (2)
  Other 2 (5) 3 (2) 5 (3)
  Otolaryngology (ENT) 2 (5) 1 (1) 3 (2)
  Paediatrics 2 (5) 3 (2) 5 (3)
  Pain 1 (3) 0 (0) 1 (1)
  Palliative care 0 (0) 3 (2) 3 (2)
  Psychiatry/psychology 2 (5) 19 (15) 21 (13)
  Public health 2 (5) 15 (12) 17 (11)
  Respiratory 0 (0) 2 (2) 2 (1)
  Rheumatology 0 (0) 1 (1) 1 (1)
  Surgery 3 (8) 8 (7) 11 (7)
  Trauma 2 (5) 7 (6) 9 (6)
Intervention type
  Drug 4 (11) 9 (7) 13 (8)
  Surgery/procedure 6 (16) 13 (11) 19 (12)
  Counselling/lifestyle/physiotherapy 22 (59) 72 (59) 94 (59)
  Equipment 4 (11) 5 (4) 9 (6)
  Other 1 (3) 24 (20) 25 (16)
Sample size target*
  Mean (SD) 72.8 (62.5) 258.5 (1215.7) 217.3 (1074.9)
  Median (IQR) 60 (32–90) 60 (40–100) 60 (40–100)
  Min- Max 6–300 20–12 000 6–12 000
Cluster randomised pilot trials (n=3) (n=18) (n=21)
Number of clusters
  Mean (SD) 7.3 (2.3) 9.7 (11.6) 9.3 (10.7)
  Median (IQR) 6 (6–10) 6 (3–10) 6 (4–10)
  Min- Max 6–10 2–45 2–45
Number of arms
  2 32 (86) 111 (90) 143 (89)
  >2 5 (14) 12 (10) 17 (11)
Number of centres
  Single centre 19 (51) 36 (29) 55 (34)
  Multicentre 18 (49) 84 (68) 102 (64)
  Unclear 0 (0) 3 (2) 3 (2)
Feasibility objective/s explicitly described as primary
  Yes 9 (24) 62 (50) 71 (44)
  No 28 (76) 61 (50) 89 (56)
Trial outcomes address trial objectives
  Yes 18 (49) 91 (74) 109 (68)
  No 0 (0) 1 (1) 1 (1)
  Somewhat† 19 (51) 31 (25) 50 (31)
Completely defined prespecified assessments or measurements stated
Table 1 Continued
Continued
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management and scientific. The domains and areas are 
listed in online supplemental file 3. Most of the areas 
were process uncertainties (34/58, 59%), which dealt 
with the feasibility of processes that are key to the success 
of the future definitive RCT.5
Four publications reported progression criteria that 
were based on detecting potential efficacy, including 
determining non- inferiority of the intervention compared 
with a comparator, determining intervention superiority 
at follow- up and finding a trend for difference between 
the intervention and comparator groups on clinical 
outcomes.
Progression criteria and quantitative indicators of feasibility
All of the pilot trial protocol and result publications 
reported using quantitative indicators of trial feasibility 
(eg, rate of recruitment and amount of missing data) to 
inform at least one of the trial’s progression criteria, with 
78% (125/160) basing all progression criteria on quanti-
tative indicators.
All but seven publications reported quantifiable numer-
ical thresholds that were, or would be, used to assess the 
progression criteria. The seven remaining publications 
did not report specific quantifiable targets for progression 
criteria, but did report how the decision to progress from 
pilot to definitive RCT would be made and the feasibility 
indicators that would be considered when making this 
decision.
The quantifiable numerical targets used were most 
often reported as a distinct threshold (eg, achieving a 
specified rate of recruitment, retention or data comple-
tion) (133/160, 83%). This was followed by a traffic light 
approach to reporting progression criteria (20/160, 
13%) with thresholds correlating to different domains 
(eg, above a higher threshold (green) indicating the 
definitive trial is feasible/proceed, within a mid/accept-
able threshold (amber) indicating that changes to defini-
tive trial are required, and below a lower threshold (red) 
indicating that the definitive trial is not feasible/not 
proceed).
Progression criteria and qualitative indicators of feasibility
Many publications reported planned or completed 
qualitative research as part of the randomised pilot trial 
(108/160, 68%). Although the findings from qualita-
tive research conducted as part of a pilot trial are often 
reported in a separate publication, the intention to 







  Yes 27 (73) 113 (92) 140 (88)
  Not for every outcome 10 (27) 10 (8) 20 (13)
Hypothesis testing
  Yes 2 (5) 16 (13) 18 (11)
  Yes, exploratory/caution advised 18 (49) 43 (35) 61 (38)
  No 17 (46) 64 (52) 81 (51)
Number of uncertainties reported
  One 0 (0) 1 (1) 1 (1)
  Multiple 37 (100) 122 (99) 159 (99)
Where uncertainties are first reported (excluding abstract)
  Introduction 0 (0) 1 (1) 1 (1)
  Research question(s) 2 (5) 4 (3) 6 (4)
  Aim(s) 5 (14) 16 (13) 21 (13)
  Objective(s) 10 (27) 62 (50) 72 (45)
  Outcome(s) 9 (24) 17 (14) 26 (16)
  Outcome measure(s) 7 (19) 16 (13) 23 (14)
  Analysis 0 (0) 2 (2) 2 (1)
  Within the text under a feasibility/uncertainty 
heading
2 (5) 1 (1) 3 (2)
  Throughout the text, not in one specific area 2 (5) 4 (3) 6 (4)
Percentages may not sum up to 100 due to rounding.
*Where publications reported a sample size target range (eg, 12–16 participants), the lower bound of the target is included. A sample size 
target was not reported in two publications (both reporting completed pilot trials and including the actual number of recruited participants).
†Trial objective was vague (eg, to ‘assess feasibility’) and the specific areas of feasibility were not explicitly stated.
ENT, ear, nose and throat.
Table 1 Continued
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Feasibility outcomes informing progression criteria
  All 14 (38) 39 (32) 53 (33)
  Some 22 (59) 77 (63) 99 (62)
  None 1 (3) 2 (2) 3 (2)
  Unclear* 0 (0) 5 (4) 5 (3)
Reported process for establishing progression criteria
Who decided on progression criteria
  Reported 4 (11) 8 (6) 12 (8)
  Not reported 33 (89) 115 (94) 148 (93)
Rationale for progression criteria
  Reported for all progression criteria 8 (22) 20 (16) 28 (18)
  Reported for some criteria only 4 (11) 12 (10) 16 (10)
  Not reported 25 (68) 91 (74) 116 (73)
Progression criteria format
Research method informing progression criteria
  Quantitative 32 (86) 93 (76) 125 (78)
  Quantitative and qualitative (mixed methods) 5 (14) 29 (24) 34 (21)
  Unclear 0 (0) 1 (1) 1 (1)
Qualitative research contribution
  Informs progression criteria 5 (14) 29 (24) 34 (21)
  Does not inform progression criteria 14 (38) 60 (49) 74 (46)
  Qualitative research methodology not used 18 (49) 34 (28) 52 (33)
Quantitative progression criteria target format
  Distinct threshold 34 (92) 99 (80) 133 (83)
  Traffic light system 2 (5) 18 (15) 20 (13)
  Other 1 (3) 6 (5) 7 (4)
Reported process for assessing progression criteria to inform the progression decision
Process for progression decision- making
  Reported 16 (43) 58 (47) 74 (46)
  Not reported 21 (57) 65 (53) 86 (54)
Who is involved in assessing progression criteria
  Reported 5 (14) 30 (24) 35 (22)
  Not reported 32 (86) 93 (76) 125 (78)
Peer reviewer reports
Progression criteria mentioned in peer reviewer report
Yes 19 (51) 67 (54) 86 (54)
  Peer review comment theme
   Progression criteria were not specified   6 (32)   29 (44)   35 (41)
   Unclear whether progression criteria were 
specified
  1 (5)   4 (6)   5 (6)
   Progression criteria rationale or justification query   5 (26)   15 (22)   20 (23)
   Other   7 (37)   19 (29)   26 (30)
No 15 (41) 52 (42) 67 (42)
Peer reviewer report unavailable 3 (8) 4 (3) 7 (4)
Continued
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be made explicit before the pilot trial commences and 
be included in the pilot trial protocol.10 The intention 
to conduct qualitative research was reported in protocols 
(89/123, 72%) more often than the results of qualitative 
research were reported in pilot trial result publications 
(19/37, 51%). However, qualitative indicators of trial 
feasibility, such as participants or researchers’ views of the 
acceptability of the trial or intervention collected in inter-
views, only informed progression criteria in 34 of the 108 
(31%) publications that reported planned or completed 
qualitative research.
Two protocols reported multiple progression criteria 
for individual feasibility indicators, for example, reporting 
both a target for number of participants recruited, and 
another target for number of participants recruited in a 
given time frame. In one of these instances, the authors 
reported that all criteria would need to be met or met 
within reasonable limits (within the green or amber 
traffic light domain) to progress to a full trial without 
major study redesign. It was unclear in the other protocol 
whether meeting one criterion for each indicator of feasi-
bility was sufficient justification for progression.
Process for establishing progression criteria
Twelve pilot trial publications reported how the progres-
sion criteria had been established, with most involving 
a trial steering or oversight committee (10/12, 83%; 
five reported having patient or public representation), 
working with funders (3/12, 25%) and/or a trial manage-
ment group (5/12, 42%; two reported having patient 
or public representation). Other examples included 
agreeing progression criteria with a data monitoring and 
ethics committee (1/12, 8%; reported having patient or 
public representation) or study physicians (1/12, 8%) or 
establishing progression criteria based on the author’s 
clinical experience (1/12, 8%).
Forty- four of the 160 publications (28%) reported 
rationale or justification for all or some of the stated 
progression criteria. For 29 publications, the stated justi-
fication was previous related research, with 25 providing 
references to previous studies. Thirteen publications 
referenced sources of guidance and methodological 
research,4 11–21 including three references to published 
guidance for internal pilot trials.2 Four publications 
reported that contextual considerations had informed 
progression criteria (such as what would be an achievable 
recruitment rate, or intervention time frame in the defin-
itive trial), and three reported that clinical considerations 
had informed criteria (including medical chart reviews, 
clinical advice and the nature of the population). Most of 
the pilot trial publications (116/160, 73%) did not report 
any rationale or justification for choice of progression 
criteria.
Process for assessing progression criteria
Nearly half of the publications (74/160, 46%) reported 
how progression criteria had or would inform the deci-
sion to progress to a future definitive RCT. This included 
whether changes to definitive RCT design would be 
considered if criteria were not strictly met (eg, were met 
within reasonable limits or within the aforementioned 
‘amber’ traffic light range), or who was or would be 
involved in assessing progression criteria.
One publication reported a two- stage decision- making 
process with different criteria assessed at each stage. Stage 
1 was to decide on the best intervention route, and stage 
2 was to decide whether to take the optimal intervention 
route forward to a definitive RCT. Another publication 
described the intention to hold a consensus conference 
of key stakeholders (patients, surgeons, public represen-
tatives and researchers) to agree whether a definitive RCT 
was feasible. Four pilot trials referred to A Process for 
Decision- making after Pilot and Feasibility Trials frame-
work11 to facilitate progression decision- making.
Nearly a quarter of publications reported who would 
be involved in assessing progression criteria (35/160, 
22%). An independent trial steering committee was 
most commonly involved (26/35, 74%). Other reported 
parties included the research team or trial management 
group (13/35, 37%), data monitoring committee (7/35, 
20%), trial sponsor (2/35, 6%), funder (1/35, 3%), inde-
pendent statistician (1/35, 3%) and other stakeholders, 
such as patients, clinicians and public representatives 
(3/35, 9%).
Intentions of completed randomised pilot trial publications
Most completed pilot trials reported that a future RCT 
would be feasible or the intention to proceed (30/37, 
81%), including the 17 completed pilot trials which met 
all of their progression criteria (table 3). Thirteen pilot 
trials met some of their progression criteria; of these, 
nine reported that a future RCT would be feasible, two 
reported that they would not proceed to a definitive 
RCT and two reported the intention to conduct further 
feasibility assessment. Four pilot trials did not meet 
their progression criteria, of which three reported that 
a future RCT would still be feasible with changes to study 
design. The extent to which progression criteria were met 







Percentages may not sum up to 100 due to rounding.
*Feasibility uncertainties are not completely defined in the objectives and outcomes; key methodological uncertainties have been 
identified from those stipulated in the progression criteria.
Table 2 Continued
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intention to conduct further feasibility assessment, and 
one reported that a future RCT would be feasible.
All but two of the completed pilot trials that reported 
that a future RCT would be feasible planned to make 
changes to their definitive RCT design (28/30, 93%). 
Of these, four reported the implications of the pilot trial 
findings in a table format, alongside whether progres-
sion criteria had or had not been met. Proposed changes 
included altering eligibility criteria, recruitment strate-
gies (eg, number of sites, recruitment materials, recruit-
ment setting), randomisation design, blinding, outcome 
measures, follow- up schedules and duration, and seeking 
additional research team support (such as a dedicated 
trial manager, research coordinator and administrative 
team). It was unclear for two pilot trials whether changes 
would be made.
Four pilot trials reported definitive RCT funding inten-
tions: two National Institute for Health Research (NIHR) 
Health Technology Assessment, one European and Devel-
oping Countries Clinical Trials Partnership, and one 
reported that a funding application had been prepared 
and submitted but did not specify the funder. One trial 
reported an anticipated progression time frame, speci-
fying a recruitment start year for the definitive RCT.
A priori progression criteria reporting of included randomised 
pilot trial publications
Trial protocols were available for 16 of the 37 (43%) 
completed randomised pilot trial publications (table 3). 
Trial registrations were identified for 20 of the trials 
without a published protocol. We were unable to iden-
tify a published protocol or trial registration for the one 
remaining completed pilot trial.
Twenty- two published protocols or trial registrations 
for the 37 included completed pilot trials did not 
report progression criteria. An additional four proto-
cols or trial registrations reported different progression 
criteria to the pilot trial result publication. Only one 
completed trial publication explained why the progres-
sion criteria had changed from the protocol: as the 
qualitative findings were reported in a separate publi-
cation, the progression criteria associated with accept-
ability were not included in the completed pilot trial 
result publication.
Table 3 Intentions reported in completed external 






  All 17 (46)
  None 4 (11)
  Some 13 (35)
  Unclear 3 (8)
Progression decision
  Proceed/future RCT is feasible 30 (81)
   With intended design 0 (0)
   With amendments 28 (93)
   Not reported whether changes will be 
made to definitive RCT design
2 (7)
   Funding intentions
   Funding for definitive RCT identified 4 (13)
    Non- industry 3 (75)
    Unclear 1 (25)
   Expected funding for definitive RCT not 
reported
26 (87)
   Timing intentions
   Time frame of expected progression 
reported
1 (3)
   Time frame of expected progression 
not reported
29 (97)
  Conduct further pilot/feasibility work 4 (11)
  Not proceed/future RCT is not feasible 3 (8)
Justification reported for the progression decision reported
  Yes 36 (97)
  No 1 (3)
Comment on data quality (eg, proportion of missing/
incomplete data from questionnaires or results)
  Yes 27 (73)
  No 10 (27)
Comment on refinement of hypotheses
  Yes 1 (3)
  No 36 (97)
Published protocol available
  Yes 16 (43)
  No 1 (3)
Alternative available (eg, trial registration or 
REC submission)
20 (54)
Progression criteria in earlier trial record (protocol or 
registration)
  No change 10 (28)
  Yes change 26 (72)






   No reason for change reported 3 (12)
   Progression criteria were not reported 
in the earlier trial record
22 (85)
Percentages may not sum up to 100 due to rounding.
RCT, randomised controlled trial; REC, Research Ethics 
Committee.
Table 3 Continued
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Progression criteria in prepublication peer reviewer reports
Prepublication peer reviewer reports were available for 
153 of the 160 (96%) included external pilot publica-
tions. Peer reviewer reports were not publicly available 
for the three PLoS One publications and peer review was 
not commissioned for four of the pilot trial protocols 
published in BMJ Open.
Table 2 shows that over half of the prepublication peer 
reviewer reports commented on progression criteria 
(86/153, 56%). Peer reviewer reports for 35 pilot trial 
publications (6 completed, 29 protocol) indicated that 
progression criteria were not reported in the submitted 
prepublication manuscript. Whether progression criteria 
were reported in the submitted prepublication manu-
script was unclear for another five pilot trial publications.
Peer reviewer reports for 20 of the publications referred 
to the rationale or justification given for progression 
criteria. For example, they asked why a specific progres-
sion criterion was set, why progression criteria were given 
for specific outcomes, how the progression criteria were 
established and how the progression decision was or will 
be made.
Peer reviewer reports for 26 pilot trial publications 
mentioned other aspects of progression criteria. For 
example, they mentioned changing where the progres-
sion criteria were reported in the manuscript (such as 
including the progression criteria in the publication 
abstract and not solely within a supplementary file), clari-
fying ambiguous wording, adding percentages in brackets 
for clarity, correcting inconsistencies in the manuscript 
and clarifying how specific criteria will be assessed. 
Reviewers also complemented authors for describing 
progression criteria well.
Not every author opted to update or add progression 
criteria to their manuscript after prepublication peer 
review. The authors of one publication argued that they 
could not alter their progression criteria because these 
criteria had been agreed by the trial management group, 
trial steering committee and ethics committee. Other 
reasons that authors gave in response to peer review for 
not reporting quantifiable numerical targets for progres-
sion criteria included: they were not set during trial 
design; strict thresholds might be influenced by contex-
tual variations that may not affect a future trial; progres-
sion criteria are best viewed as guidelines in line with the 
CONSORT extension statement; different perspectives 
could not be successfully captured by a set of criteria; and 
the trial is not an internal pilot.
DISCUSSION
Summary of main findings
Our study provides an assessment of the reporting 
of progression criteria in a large sample of external 
randomised pilot trials. We found that progression 
criteria varied widely and were not often justified, which 
agrees with recent research assessing the use of progres-
sion criteria in internal pilot trials.22 23 Like internal pilots, 
many of the studied external randomised pilot trials 
reported the intention to proceed to a definitive RCT 
when they had not strictly met all progression criteria, 
demonstrating flexibility in approach to progression 
decision- making with many opting to make changes to the 
definitive trial design. It was unclear within the studied 
publications how, or by whom, progression criteria are 
established and assessed.
Our findings suggest that guidance is needed to facili-
tate transparent and complete reporting of progression 
criteria a priori in external pilot trial protocols3 and in 
pilot trial results publications.24
Strengths and weaknesses of the study
A study strength is our extensive recent sample of 160 
publications reporting external randomised pilot trials in 
four key journals that are known to publish pilot trials.
A limitation of this study is that single screening was 
used, and double data extraction was only conducted for 
25% of the included publications. However, since only 
minimal data extraction differences were identified we 
decided not to conduct double data extraction for all 
included publications.
We only included external randomised pilot trials and 
it is unclear whether these findings are generalisable 
to other external feasibility study designs, such as non- 
randomised pilot trials and non- pilot feasibility studies. 
Our findings are also limited to four included journals and 
we did not include publications of non- English language 
which could introduce potential language bias.25
In addition, our review of peer reviewer reports to 
assess the context in which progression criteria were 
mentioned was subject to interpretation. Prepublication 
peer reviewer reports were not available for all included 
publications: PLoS One allows authors to opt in to publish 
peer reviewer reports, and peer review was not commis-
sioned for four pilot trial protocols published in BMJ 
Open that had already been peer reviewed for ethical and 
funding approval before submission. Progression criteria 
might also have been added or altered based on editorial 
review before peer review. Unlike peer reviewer reports, it 
is not common practice to make editorial review publicly 
available.
Meaning of the study: possible explanations and implications 
for clinicians and policymakers
Our findings suggest that the research community is 
uncertain about how progression criteria should be 
applied to external randomised pilot trials and how this 
should be reported in protocol and results publications. 
We identified one instance within a peer reviewer report 
for a pilot trial protocol where authors had stated that 
progression criteria were not set because the trial was not 
an internal pilot and as such would not immediately prog-
ress to a fully powered RCT.
We found recruitment and retention rates to be the most 
common feasibility uncertainties to contribute towards 
progression criteria. This result is supported by a recent 
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review finding recruitment to be the most common uncer-
tainty evaluated in surgical pilot and feasibility studies,26 
and is unsurprising considering that recruiting to target 
is a challenge for many RCTs.27 Fairhurst and colleagues 
suggested that researchers conducting feasibility studies 
might focus on feasibility uncertainties that are perceived 
to be important to funders.26 In support of this sugges-
tion, we found that other feasibility uncertainties that are 
equally as important to trial success, such as intervention 
acceptability, contributed to progression criteria much 
less often than recruitment and retention.
We found that peer review improved the reporting of 
pilot trials, for example, by prompting authors to explain 
their progression criteria and rationale. However, we also 
identified instances where new progression criteria were 
likely added as a result of peer review, in both protocols 
and pilot trial result manuscripts. Adding post hoc progres-
sion criteria could introduce bias since progression criteria 
might be based on targets that have been met or exceeded 
to justify progression to a definitive RCT.
Unanswered questions and future research
The processes for establishing and assessing progression 
criteria were not commonly reported, leaving unanswered 
questions about how the decision to progress from pilot to 
definitive RCT is made in practice. This under- reporting 
could be due to a lack of guidance around best practices 
for progression of external randomised pilot trials, and 
how this should be reported in pilot trial publications. 
To expand on these findings a qualitative research study 
is being conducted to explore different stakeholders’ 
perspectives and experiences of using progression criteria 
to inform the decision to progress from an external 
randomised pilot trial to a definitive RCT in practice.28 Our 
findings also highlight the importance of journal editor 
and peer reviewer endorsement of evidence- based guide-
lines to improve reporting standards. The development of 
evidence- based guidance specific to the application and 
reporting of progression criteria in external pilot trials, for 
both protocols and completed trials, is a research priority. 
This finding is timely, as the UK’s biggest funder of pilot and 
feasibility studies, NIHR Research for Patient Benefit, now 
stipulates that a clear route of progression (eg, progression 
criteria) should be included in pilot and feasibility study 
funding applications.29 A further possible area of investiga-
tion is whether research ethics committees can and should 
comment on progression criteria in research ethics appli-
cations. Researchers have an ethical obligation to conduct 
research with integrity and transparency. Defining a priori 
progression criteria and adequately reporting them helps 
to uphold the integrity and transparency of the external 
randomised pilot trial’s progression.
CONCLUSIONS
We found heterogeneity in the reporting of progression 
criteria in external randomised pilot trial publications. 
It was often unclear how progression criteria were estab-
lished, on what justification or rationale they were based, 
how they were or will be assessed and who is involved at 
each stage. Peer reviewers often commented on progres-
sion criteria, questioning whether these criteria were 
established a priori, as is recommended for good practice. 
Clear, evidence- based recommendations for the use and 
reporting of progression criteria in external randomised 
pilot trials are required. Guidance to this effect would 
benefit researchers, peer reviewers, journal editors and 
funders of external randomised pilot trials, and inform the 
design of subsequent definitive trials. In the meantime, we 
suggest researchers consider reporting how their progres-
sion criteria were established in their pilot trial protocol 
publications, and how their findings in relation to progres-
sion criteria have informed progression decision- making 
and the subsequent definitive trial design in pilot trial 
results publications.
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feasibility randomised controlled trial 
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Hughes 2018 BMJ Open Prediabetes in pregnancy, can early intervention improve outcomes? A feasibility study for a parallel randomised 
clinical trial 
Jolly 2018 BMJ Open Protocol for a feasibility trial for improving breast feeding initiation and continuation: Assets-based infant 
feeding help before and after birth (ABA) 
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Protocol for a pilot randomised controlled trial in the UK - The Ankle Fracture Treatment: Enhancing 
Rehabilitation (AFTER) study 
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Pai 2019 BMJ Open Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy 
of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial 
Papathanassoglou 2019 BMJ Open Relaxation for Critically ill Patient Outcomes and S tress-coping Enhancement (REPOSE): A protocol for a pilot 
randomised trial of an integrative intervention to improve critically ill patients' delirium and related outcomes 
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of faecal microbiota transplant delivery in patients with ulcerative colitis 
Reddington 2018 BMJ Open Does early intervention improve outcomes in the physiotherapy management of lumbar radicular syndrome? 
Results of the POLAR pilot randomised controlled trial 
Ribeiro 2019 BMJ Open Effectiveness of a tailored rehabilitation versus standard strengthening programme for patients with shoulder 
pain: A protocol for a feasibility randomised controlled trial (the Otago MASTER trial) 
Schults 2018 BMJ Open Normal saline instillation versus no normal saline instillation and lung Recruitment versus no lung recruitment 
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SUPPLEMENTARY FILE 3: INDICATOR OF FEASIBILITY CONTRIBUTING TO PROGRESSION CRITERIA 
 
Domain Indicator of feasibility contributing to progression criteria 
Number of 
publications 
Management Data completion or missing data 38 
 Barriers or challenges to intervention implementation 7 
 Develop or test training materials 4 
 Protocol components work together 2 
 Data analysis 2 
 Data collection methods are suitable/fit for purpose 1 
 Data management 1 
 Time to Ethics approvals at each site 1 
 Time to readiness to initiate the clinical trial 1 
Process Recruitment rates 113 
 Retention or attrition rate 106 
 Non(compliance) or adherence rate (participants) 66 
 Intervention acceptability or evaluation (patients) 33 
 Withdrawal or completion rate (trial or intervention) 22 
 Intervention acceptability or evaluation (non-patients) 17 
 Consent or refusal rate 16 
 Randomisation acceptability or rate 15 
 Intervention fidelity 15 
 
Understanding or acceptability of data collection 
tools/assessments/methods 
14 
 Non(compliance) or adherence rates (non-participants) 12 
 Participant identification or screening 10 
 Eligibility rate 9 
 Trial acceptability or evaluation (patients) 8 
 Characteristics or properties of trial outcome measures 7 
 Randomisation adequacy 5 
 Crossover or contamination between arms 4 
 Enrolment rate 5 
 Uptake or engagement rate 3 
 Definitive study sample size is achievable 3 
 Trial acceptability or evaluation (non-patients) 2 
 Success or failure rate 2 
 Understanding or acceptability of study instructions 2 
 Blinding procedures 1 
 Eligibility criteria 1 
 Describe control group 2 
 Recruitment process 2 
 Understanding or acceptability of study information 1 
 Allocation concealment 1 
 Intervention credibility 1 
 Intervention suitability 1 
 Completeness of biological sample collection 1 
 Interest in using the intervention post-study 1 
 Positive expected net gain of sampling from a definitive trial 1 
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Resources Centre or investigator recruitment, willingness or capacity 21 
 Determining process time 7 
 
Collection of outcomes relevant to future economic 
evaluation 
4 
 Equipment or resource reliability 2 
 Venue, location or setting appropriate 1 
 Determining capacity 1 
 Intervention agreement between methods 1 
Scientific Safety, adverse events, unintended consequences or harms 25 
 Estimate of treatment effect 11 
 Estimate of variance of treatment effect 6 
 Patient response 5 
 Signal of efficacy 4 
 Estimate intracluster correlation coefficient  1 
 Context and mechanisms of action 1 
 Intervention tolerability 1 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2020-048178:e048178. 11 2021;BMJ Open, et al. Mellor K
